1. Home
  2. SRPT vs BPOPM Comparison

SRPT vs BPOPM Comparison

Compare SRPT & BPOPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • BPOPM
  • Stock Information
  • Founded
  • SRPT 1980
  • BPOPM N/A
  • Country
  • SRPT United States
  • BPOPM United States
  • Employees
  • SRPT N/A
  • BPOPM N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • BPOPM Major Banks
  • Sector
  • SRPT Health Care
  • BPOPM Finance
  • Exchange
  • SRPT Nasdaq
  • BPOPM Nasdaq
  • Market Cap
  • SRPT 2.0B
  • BPOPM N/A
  • IPO Year
  • SRPT 1997
  • BPOPM N/A
  • Fundamental
  • Price
  • SRPT $17.48
  • BPOPM $25.17
  • Analyst Decision
  • SRPT Hold
  • BPOPM
  • Analyst Count
  • SRPT 31
  • BPOPM 0
  • Target Price
  • SRPT $40.61
  • BPOPM N/A
  • AVG Volume (30 Days)
  • SRPT 7.8M
  • BPOPM N/A
  • Earning Date
  • SRPT 11-05-2025
  • BPOPM N/A
  • Dividend Yield
  • SRPT N/A
  • BPOPM N/A
  • EPS Growth
  • SRPT N/A
  • BPOPM N/A
  • EPS
  • SRPT N/A
  • BPOPM N/A
  • Revenue
  • SRPT $2,481,531,000.00
  • BPOPM N/A
  • Revenue This Year
  • SRPT $10.78
  • BPOPM N/A
  • Revenue Next Year
  • SRPT N/A
  • BPOPM N/A
  • P/E Ratio
  • SRPT N/A
  • BPOPM N/A
  • Revenue Growth
  • SRPT 64.89
  • BPOPM N/A
  • 52 Week Low
  • SRPT $10.42
  • BPOPM N/A
  • 52 Week High
  • SRPT $138.81
  • BPOPM N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 44.35
  • BPOPM 55.95
  • Support Level
  • SRPT $16.85
  • BPOPM $25.01
  • Resistance Level
  • SRPT $19.27
  • BPOPM $25.27
  • Average True Range (ATR)
  • SRPT 0.93
  • BPOPM 0.05
  • MACD
  • SRPT -0.13
  • BPOPM 0.02
  • Stochastic Oscillator
  • SRPT 22.79
  • BPOPM 72.97

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About BPOPM Popular Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities

Popular Capital Trust II is a statutory trust. It is engaged in issuing capital securities.

Share on Social Networks: